Century Therapeutics, Inc. (IPSC) · INSIDERData sourcesSEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago
Public companyCentury Therapeutics, Inc.
IPSCCIK 0001850119
Price$1.68
1 year+200.0%
Disclosed transactions44
Buys / sells3 / 16
Max Insider Score51
Connections with evidence7
IPSC · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 14 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $404 266 sh | Nov 3, 2026 | Nov 5, 2026 |
| 19 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $3,200 1,658 sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 5 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $27K 13.8K sh | Sep 11, 2026 | Sep 15, 2026 traded Sep 11, 2026 | +4d | SEC Form 4 | |
| 22 | RGRussotti GregorySee Remarks | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $4,993 2,587 sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 22 | RGRussotti GregorySee Remarks | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $1,095 534 sh | Sep 8, 2026 | Sep 9, 2026 traded Sep 8, 2026 | +1d | SEC Form 4 | |
| 11 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $977 463 sh | Sep 4, 2026 | Sep 9, 2026 traded Sep 4, 2026 | +5d | SEC Form 4 | |
| 19 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $521 254 sh | Sep 8, 2026 | Sep 9, 2026 traded Sep 8, 2026 | +1d | SEC Form 4 | |
| 8 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $60K 31.2K sh | Aug 14, 2026 | Aug 18, 2026 traded Aug 14, 2026 | +4d | SEC Form 4 | |
| 5 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $31K 13.8K sh | Jun 11, 2026 | Jun 15, 2026 traded Jun 11, 2026 | +4d | SEC Form 4 | |
| 22 | RGRussotti GregorySee Remarks | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $5,767 2,584 sh | Jun 12, 2026 | Jun 15, 2026 traded Jun 12, 2026 | +3d | SEC Form 4 | |
| 5 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Tax withholding | F | $802 358 sh | Jun 11, 2026 | Jun 15, 2026 traded Jun 11, 2026 | +4d | SEC Form 4 | |
| 22 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $3,692 1,654 sh | Jun 12, 2026 | Jun 15, 2026 traded Jun 12, 2026 | +3d | SEC Form 4 | |
| 9 | | IPSCCentury Therapeutics, Inc. Grant or award | A | — 74.0K sh | Jun 11, 2026 | Jun 12, 2026 traded Jun 11, 2026 | +1d | SEC Form 4 | |
| 9 | MPMurphy Martin PatrickDirector | IPSCCentury Therapeutics, Inc. Grant or award | A | — 74.0K sh | Jun 11, 2026 | Jun 12, 2026 traded Jun 11, 2026 | +1d | SEC Form 4 | |
| 5 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $986 463 sh | Jun 5, 2026 | Jun 9, 2026 traded Jun 5, 2026 | +4d | SEC Form 4 | |
| 22 | RGRussotti GregorySee Remarks | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $1,106 524 sh | Jun 8, 2026 | Jun 9, 2026 traded Jun 8, 2026 | +1d | SEC Form 4 | |
| 22 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $526 249 sh | Jun 8, 2026 | Jun 9, 2026 traded Jun 8, 2026 | +1d | SEC Form 4 | |
| 8 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $73K 31.2K sh | May 15, 2026 | May 19, 2026 traded May 15, 2026 | +4d | SEC Form 4 | |
| 17 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $618 264 sh | May 4, 2026 | May 6, 2026 traded May 4, 2026 | +2d | SEC Form 4 | |
| 24 | MPMurphy Martin PatrickDirector | IPSCCentury Therapeutics, Inc. Grant or award | A | — 88.0K sh | Dec 9, 2025 | Apr 10, 2026 traded Dec 9, 2025 | +122d | SEC Form 4 | |
| 5 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Tax withholding | F | $2,989 1,365 sh | Apr 1, 2026 | Apr 3, 2026 traded Apr 1, 2026 | +2d | SEC Form 4 | |
| 8 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $151K 55.4K sh | Mar 11, 2026 | Mar 13, 2026 traded Mar 11, 2026 | +2d | SEC Form 4 | |
| 5 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Tax withholding | F | $3,907 1,431 sh | Mar 11, 2026 | Mar 13, 2026 traded Mar 11, 2026 | +2d | SEC Form 4 | |
| 5 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $1,185 463 sh | Mar 6, 2026 | Mar 10, 2026 traded Mar 6, 2026 | +4d | SEC Form 4 | |
| 17 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $589 323 sh | Feb 3, 2026 | Feb 5, 2026 traded Feb 3, 2026 | +2d | SEC Form 4 | |
| 13 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Grant or award | A | — 110.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 5 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Grant or award | A | — 265.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 5 | RGRussotti GregorySee Remarks | IPSCCentury Therapeutics, Inc. Grant or award | A | — 265.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 5 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Grant or award | A | — 945.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 9 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Grant or award | A | — 135.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 5 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Grant or award | A | — 225.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 13 | RGRussotti GregorySee Remarks | IPSCCentury Therapeutics, Inc. Grant or award | A | — 135.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 9 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Grant or award | A | — 475.0K sh | Feb 2, 2026 | Feb 4, 2026 traded Feb 2, 2026 | +2d | SEC Form 4 | |
| 5 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Tax withholding | F | $1,603 1,611 sh | Jan 2, 2026 | Jan 6, 2026 traded Jan 2, 2026 | +4d | SEC Form 4 | |
| 51 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Open-market purchase | BUY | $49K 58.1K sh | Dec 22, 2025 | Dec 29, 2025 traded Dec 22, 2025 | +7d | SEC Form 4 | |
| 30 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Open-market purchase | BUY | $30K 52.0K sh | Dec 12, 2025 | Dec 16, 2025 traded Dec 12, 2025 | +4d | SEC Form 4 | |
| 5 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $244 463 sh | Dec 10, 2025 | Dec 12, 2025 traded Dec 10, 2025 | +2d | SEC Form 4 | |
| 9 | | IPSCCentury Therapeutics, Inc. Grant or award | A | — 88.0K sh | Dec 9, 2025 | Dec 11, 2025 traded Dec 9, 2025 | +2d | SEC Form 4 | |
| 26 | RGRussotti GregorySee Remarks | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $280 526 sh | Dec 8, 2025 | Dec 10, 2025 traded Dec 8, 2025 | +2d | SEC Form 4 | |
| 22 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $137 257 sh | Dec 8, 2025 | Dec 10, 2025 traded Dec 8, 2025 | +2d | SEC Form 4 | |
| 26 | CCCowan ChadChief Scientific Officer | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $2,736 5,462 sh | Nov 20, 2025 | Nov 24, 2025 traded Nov 20, 2025 | +4d | SEC Form 4 | |
| 36 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Open-market purchase | BUY | $17K 35.0K sh | Nov 19, 2025 | Nov 20, 2025 traded Nov 19, 2025 | +1d | SEC Form 4 | |
| 31 | PBPfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $15K 32.5K sh | Nov 17, 2025 | Nov 19, 2025 traded Nov 17, 2025 | +2d | SEC Form 4 | |
| 26 | CDCarr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $171 292 sh | Nov 3, 2025 | Nov 5, 2025 traded Nov 3, 2025 | +2d | SEC Form 4 | |
Chief Scientific Officer · Nov 24, 2025
Planned sales and 5% stakes
Form 144, 13D and 13G